HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cardiac contractility after transplantation of autologous mononuclear bone marrow cells in patients with myocardial infarction.

Abstract
Autologous bone marrow mononuclear cells were transplanted by intracoronary infusion to patients with myocardial infarction after recovery of coronary perfusion. Controls received traditional therapy alone. Echocardiography was carried out before and 3 and 6 months after cell therapy. Cell transplantation did not appreciably improved left-ventricular contractility in comparison with the control group. In none patient cell therapy provoked malignant ventricular arrhythmias. Intracoronary infusion of bone marrow mononuclear cells in patients with myocardial infarction did not improve cardiac contractility and did not aggravate the course of the disease.
AuthorsV V Ryabov, A L Krylov, Yu S Poponina, L N Maslov
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 141 Issue 1 Pg. 124-8 (Jan 2006) ISSN: 0007-4888 [Print] United States
PMID16929983 (Publication Type: Controlled Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Aged
  • Bone Marrow Transplantation
  • Electrocardiography
  • Female
  • Heart Ventricles (physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Myocardial Contraction
  • Myocardial Infarction (therapy)
  • Transplantation, Autologous
  • Ventricular Function

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: